1
|
Ponikowski P, Voors AA, Anker SD, Bueno H,
Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP,
Jankowska EA, et al: 2016 ESC guidelines for the diagnosis and
treatment of acute and chronic heart failure: The task force for
the diagnosis and treatment of acute and chronic heart failure of
the European society of cardiology (ESC). Developed with the
special contribution of the heart failure association (HFA) of the
ESC. Eur J Heart Fail. 18:891–975. 2016.PubMed/NCBI View Article : Google Scholar
|
2
|
Dunlay SM, Roger VL and Redfield MM:
Epidemiology of heart failure with preserved ejection fraction. Nat
Rev Cardiol. 14:591–602. 2017.PubMed/NCBI View Article : Google Scholar
|
3
|
Ge J: Coding proposal on phenotyping heart
failure with preserved ejection fraction: A practical tool for
facilitating etiology-oriented therapy. Cardiol J. 27:97–98.
2020.PubMed/NCBI View Article : Google Scholar
|
4
|
Mohan S, Gu S, Parikh A and Radhakrishnan
J: Prevalence of hyponatremia and association with mortality:
Results from NHANES. Am J Med. 126:1127–1137.e1. 2013.PubMed/NCBI View Article : Google Scholar
|
5
|
Rossi J, Bayram M, Udelson JE, Lloyd-Jones
D, Adams KF, Oconnor CM, Stough WG, Ouyang J, Shin DD, Orlandi C
and Gheorghiade M: Improvement in hyponatremia during
hospitalization for worsening heart failure is associated with
improved outcomes: Insights from the acute and chronic therapeutic
impact of a vasopressin antagonist in chronic heart failure (ACTIV
in CHF) trial. Acute Card Care. 9:82–86. 2007.PubMed/NCBI View Article : Google Scholar
|
6
|
Gheorghiade M, Abraham WT, Albert NM,
Gattis Stough W, Greenberg BH, O'Connor CM, She L, Yancy CW, Young
J and Fonarow GC: OPTIMIZE-HF Investigators and Coordinators.
Relationship between admission serum sodium concentration and
clinical outcomes in patients hospitalized for heart failure: An
analysis from the OPTIMIZE-HF registry. Eur Heart J. 28:980–988.
2007.PubMed/NCBI View Article : Google Scholar
|
7
|
Gheorghiade M, Rossi JS, Cotts W, Shin DD,
Hellkamp AS, Piña IL, Fonarow GC, DeMarco T, Pauly DF, Rogers J, et
al: Characterization and prognostic value of persistent
hyponatremia in patients with severe heart failure in the ESCAPE
Trial. Arch Intern Med. 167:1998–2005. 2007.PubMed/NCBI View Article : Google Scholar
|
8
|
Lu DY, Cheng HM, Cheng YL, Hsu PF, Huang
WM, Guo CY, Yu WC, Chen CH and Sung SH: Hyponatremia and worsening
sodium levels are associated with long-term outcome in patients
hospitalized for acute heart failure. J Am Heart Assoc.
5(e002668)2016.PubMed/NCBI View Article : Google Scholar
|
9
|
Patel YR, Kurgansky KE, Imran TF, Orkaby
AR, McLean RR, Ho YL, Cho K, Gaziano JM, Djousse L, Gagnon DR and
Joseph J: Prognostic significance of baseline serum sodium in heart
failure with preserved ejection fraction. J Am Heart Assoc.
7(e007529)2018.PubMed/NCBI View Article : Google Scholar
|
10
|
Park JJ, Cho YJ, Oh IY, Park HA, Lee HY,
Kim KH, Yoo BS, Kang SM, Baek SH, Jeon ES, et al: Short and
long-term prognostic value of hyponatremia in heart failure with
preserved ejection fraction versus reduced ejection fraction: An
analysis of the Korean acute heart failure registry. Int J Cardiol.
248:239–245. 2017.PubMed/NCBI View Article : Google Scholar
|
11
|
McKee PA, Castelli WP, McNamara PM and
Kannel WB: The natural history of congestive heart failure: The
Framingham study. N Engl J Med. 285:1441–1446. 1971.PubMed/NCBI View Article : Google Scholar
|
12
|
Lang RM, Badano LP, Mor-Avi V, Afilalo J,
Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA,
Kuznetsova T, et al: Recommendations for cardiac chamber
quantification by echocardiography in adults: An update from the
American society of echocardiography and the European association
of cardiovascular imaging. J Am Soc Echocardiogr. 28:1–39.e14.
2015.PubMed/NCBI View Article : Google Scholar
|
13
|
Cabuk AK, Cabuk G, Sayin A, Karamanlioglu
M, Kilicaslan B, Ekmekci C, Solmaz H, Aslanturk OF and Ozdogan O:
Do we overestimate left ventricular ejection fraction by
two-dimensional echocardiography in patients with left bundle
branch block? Echocardiography. 35:148–152. 2018.PubMed/NCBI View Article : Google Scholar
|
14
|
Bavishi C, Ather S, Bambhroliya A, Jneid
H, Virani SS, Bozkurt B and Deswal A: Prognostic significance of
hyponatremia among ambulatory patients with heart failure and
preserved and reduced ejection fractions. Am J Cardiol.
113:1834–1838. 2014.PubMed/NCBI View Article : Google Scholar
|
15
|
Kusaka H, Sugiyama S, Yamamoto E, Akiyama
E, Matsuzawa Y, Hirata Y, Fujisue K, Kurokawa H, Matsubara J,
Sugamura K, et al: Low-normal serum sodium and heart
failure-related events in patients with heart failure with
preserved left ventricular ejection fraction. Circ J. 80:411–417.
2016.PubMed/NCBI View Article : Google Scholar
|
16
|
Rusinaru D, Buiciuc O, Leborgne L, Slama
M, Massy Z and Tribouilloy C: Relation of serum sodium level to
long-term outcome after a first hospitalization for heart failure
with preserved ejection fraction. Am J Cardiol. 103:405–410.
2009.PubMed/NCBI View Article : Google Scholar
|
17
|
Upadhyay A, Jaber BL and Madias NE:
Incidence and prevalence of hyponatremia. Am J Med. 119 (7 Suppl
1):S30–S35. 2006.PubMed/NCBI View Article : Google Scholar
|
18
|
Gheorghiade M, Gattis WA, O'Connor CM,
Adams KF Jr, Elkayam U, Barbagelata A, Ghali JK, Benza RL, McGrew
FA, Klapholz M, et al: Effects of tolvaptan, a vasopressin
antagonist, in patients hospitalized with worsening heart failure:
A randomized controlled trial. JAMA. 291:1963–1971. 2004.PubMed/NCBI View Article : Google Scholar
|
19
|
Klein L, O'Connor CM, Leimberger JD,
Gattis-Stough W, Piña IL, Felker GM, Adams KF Jr, Califf RM and
Gheorghiade M: OPTIME-CHF Investigators. Lower serum sodium is
associated with increased short-term mortality in hospitalized
patients with worsening heart failure: Results from the outcomes of
a prospective trial of intravenous milrinone for exacerbations of
chronic heart failure (OPTIME-CHF) study. Circulation.
111:2454–2460. 2005.PubMed/NCBI View Article : Google Scholar
|
20
|
Stolfo D, Uijl A, Vedin O, Strömberg A,
Faxén UL, Rosano GMC, Sinagra G, Dahlström U and Savarese G:
Sex-based differences in heart failure across the ejection fraction
spectrum: Phenotyping, and prognostic and therapeutic implications.
JACC Heart Fail. 7:505–515. 2019.PubMed/NCBI View Article : Google Scholar
|
21
|
Baldasseroni S, Urso R, Orso F, Bianchini
BP, Carbonieri E, Cirò A, Gonzini L, Leonardi G, Marchionni N and
Maggioni AP: IN-CHF Investigators. Relation between serum sodium
levels and prognosis in outpatients with chronic heart failure:
Neutral effect of treatment with beta-blockers and
angiotensin-converting enzyme inhibitors: Data from the Italian
network on congestive heart failure (IN-CHF database). J Cardiovasc
Med (Hagerstown). 12:723–731. 2011.PubMed/NCBI View Article : Google Scholar
|
22
|
Lee WH and Packer M: Prognostic importance
of serum sodium concentration and its modification by
converting-enzyme inhibition in patients with severe chronic heart
failure. Circulation. 73:257–267. 1986.PubMed/NCBI View Article : Google Scholar
|
23
|
Yoo BS, Park JJ, Choi DJ, Kang SM, Hwang
JJ, Lin SJ, Wen MS, Zhang J and Ge J: COAST investigators.
Prognostic value of hyponatremia in heart failure patients: An
analysis of the clinical characteristics and outcomes in the
relation with serum sodium level in asian patients hospitalized for
heart failure (COAST) study. Korean J Intern Med. 30:460–470.
2015.PubMed/NCBI View Article : Google Scholar
|
24
|
Abraham WT, Fonarow GC, Albert NM, Stough
WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW and
Young JB: OPTIMIZE-HF Investigators and Coordinators. Predictors of
in-hospital mortality in patients hospitalized for heart failure:
Insights from the organized program to initiate lifesaving
treatment in hospitalized patients with heart failure
(OPTIMIZE-HF). J Am Coll Cardiol. 52:347–356. 2008.PubMed/NCBI View Article : Google Scholar
|
25
|
Vergaro G, Aimo A, Prontera C, Ghionzoli
N, Arzilli C, Zyw L, Taddei C, Gabutti A, Poletti R, Giannoni A, et
al: Sympathetic and renin-angiotensin-aldosterone system activation
in heart failure with preserved, mid-range and reduced ejection
fraction. Int J Cardiol. 296:91–97. 2019.PubMed/NCBI View Article : Google Scholar
|
26
|
Azim A and Jena S: BNP: Is it an ideal
marker to assess volume status in patients with hyponatremia and
natriuresis? Neurol India. 66:1392–1393. 2018.PubMed/NCBI View Article : Google Scholar
|
27
|
Tobin G, Chacko AG and Simon R: Evaluation
of NT-ProBNP as a marker of the volume status of neurosurgical
patients developing hyponatremia and natriuresis: A pilot study.
Neurol India. 66:1383–1388. 2018.PubMed/NCBI View Article : Google Scholar
|
28
|
Wannamethee G, Whincup PH, Shaper AG and
Lever AF: Serum sodium concentration and risk of stroke in
middle-aged males. J Hypertens. 12:971–979. 1994.PubMed/NCBI
|
29
|
Zheng B, Qiu Y, Jin H, Wang L, Chen X, Shi
C and Zhao S: A predictive value of hyponatremia for poor outcome
and cerebral infarction in high-grade aneurysmal subarachnoid
haemorrhage patients. J Neurol Neurosurg Psychiatry. 82:213–217.
2011.PubMed/NCBI View Article : Google Scholar
|
30
|
Writing Group Members. Mozaffarian D,
Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de
Ferranti S, Després JP, et alHeart disease and stroke
statistics-2016 update: A report from the American heart
association. Circulation. 133:e38–e360. 2016.PubMed/NCBI View Article : Google Scholar
|
31
|
McGirt MJ, Blessing R, Nimjee SM, Friedman
AH, Alexander MJ, Laskowitz DT and Lynch JR: Correlation of serum
brain natriuretic peptide with hyponatremia and delayed ischemic
neurological deficits after subarachnoid hemorrhage. Neurosurgery.
54:1369–1373; discussion 1373-1364. 2004.PubMed/NCBI View Article : Google Scholar
|
32
|
Verbrugge FH, Steels P, Grieten L, Nijst
P, Tang WH and Mullens W: Hyponatremia in acute decompensated heart
failure: Depletion versus dilution. J Am Coll Cardiol. 65:480–492.
2015.PubMed/NCBI View Article : Google Scholar
|